Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 166
9
Diseases
13
Unique genes
0.283
Avg. similarity score
Congenital asplenia
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital asplenia
Interrupted aortic arch
NKX2.5-related congenital, conduction and myopathic heart disease
Deletion 5q35 syndrome
Myotonic dystrophy
Splenic hypoplasia
Asplenia
Congenital septal defect of heart
Congenital-onset steinert myotonic dystrophy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital asplenia | 6 | 6 | 2 |
| Interrupted aortic arch | 6 | 6 | 1 |
| NKX2.5-related congenital, conduction and myopathic heart disease | 6 | 6 | 1 |
| Deletion 5q35 syndrome | 5 | 5 | 2 |
| Myotonic dystrophy | 5 | 5 | 5 |
| Splenic hypoplasia | 5 | 5 | 2 |
| Asplenia | 2 | 2 | 1 |
| Congenital septal defect of heart | 2 | 2 | 7 |
| Congenital-onset steinert myotonic dystrophy | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| NKX2-5 | 7 / 9 | Congenital asplenia, Congenital septal defect of heart, Deletion 5q35 syndrome, Interrupted aortic arch and 3 more |
| RPSA | 3 / 9 | Asplenia, Congenital asplenia, Splenic hypoplasia |
| DMPK | 2 / 9 | Congenital-onset steinert myotonic dystrophy, Myotonic dystrophy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE | Reactome | 1 / 2 | 462× | 2.16e-3 | 2.42e-2 ✓ sig. |
| Defective MTR causes methylmalonic aciduria and homocystinuria type cblG | Reactome | 1 / 2 | 462× | 2.16e-3 | 2.42e-2 ✓ sig. |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | Reactome | 1 / 4 | 231× | 4.32e-3 | 3.98e-2 ✓ sig. |
| NGF processing | Reactome | 1 / 4 | 231× | 4.32e-3 | 3.98e-2 ✓ sig. |
| Sulfur amino acid metabolism | Reactome | 1 / 6 | 154× | 6.48e-3 | 5.19e-2 |
| FOXO-mediated transcription of cell death genes | Reactome | 1 / 9 | 103× | 9.70e-3 | 6.74e-2 |
| Regulation of gene expression by Hypoxia-inducible Factor | Reactome | 1 / 11 | 84.0× | 1.18e-2 | 7.60e-2 |
| Assembly of active LPL and LIPC lipase complexes | Reactome | 1 / 11 | 84.0× | 1.18e-2 | 7.60e-2 |
| Activation of the TFAP2 (AP-2) family of transcription factors | Reactome | 1 / 12 | 77.0× | 1.29e-2 | 7.95e-2 |
| Physiological factors | Reactome | 1 / 12 | 77.0× | 1.29e-2 | 7.95e-2 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | Reactome | 1 / 14 | 66.0× | 1.51e-2 | 8.71e-2 |
| Methylation | Reactome | 1 / 14 | 66.0× | 1.51e-2 | 8.71e-2 |
| Cobalamin transport and metabolism | KEGG | 1 / 18 | 51.3× | 1.93e-2 | 1.01e-1 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | Reactome | 1 / 21 | 44.0× | 2.25e-2 | 1.10e-1 |
| Signaling by BMP | Reactome | 1 / 28 | 33.0× | 2.99e-2 | 1.29e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| endocardial cushion development | GO:0003197 | 3 / 13 | 332× | 7.49e-8 | 9.46e-6 ✓ sig. |
| outflow tract morphogenesis | GO:0003151 | 4 / 63 | 91.3× | 8.20e-8 | 1.02e-5 ✓ sig. |
| cardiac muscle tissue development | GO:0048738 | 3 / 24 | 180× | 5.28e-7 | 4.89e-5 ✓ sig. |
| outflow tract septum morphogenesis | GO:0003148 | 3 / 28 | 154× | 8.53e-7 | 7.28e-5 ✓ sig. |
| ventricular septum morphogenesis | GO:0060412 | 3 / 41 | 105× | 2.76e-6 | 1.86e-4 ✓ sig. |
| embryonic heart tube left/right pattern formation | GO:0060971 | 2 / 6 | 479× | 6.69e-6 | 3.78e-4 ✓ sig. |
| heart looping | GO:0001947 | 3 / 64 | 67.4× | 1.07e-5 | 5.49e-4 ✓ sig. |
| atrial septum morphogenesis | GO:0060413 | 2 / 13 | 221× | 3.47e-5 | 1.37e-3 ✓ sig. |
| embryonic camera-type eye morphogenesis | GO:0048596 | 2 / 15 | 192× | 4.67e-5 | 1.71e-3 ✓ sig. |
| cardiac septum morphogenesis | GO:0060411 | 2 / 16 | 180× | 5.33e-5 | 1.89e-3 ✓ sig. |
| pharyngeal system development | GO:0060037 | 2 / 21 | 137× | 9.31e-5 | 2.87e-3 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 5 / 778 | 9.2× | 1.20e-4 | 3.47e-3 ✓ sig. |
| embryonic heart tube development | GO:0035050 | 2 / 26 | 111× | 1.44e-4 | 3.97e-3 ✓ sig. |
| vasculature development | GO:0001944 | 2 / 33 | 87.1× | 2.33e-4 | 5.62e-3 ✓ sig. |
| regulation of heart contraction | GO:0008016 | 2 / 36 | 79.9× | 2.78e-4 | 6.35e-3 ✓ sig. |